| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 6.66e-10 | 37 | 168 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 8.38e-10 | 38 | 168 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 7.48e-08 | 14 | 168 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | translation activator activity | 1.11e-07 | 15 | 168 | 5 | GO:0008494 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.52e-06 | 11 | 168 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.59e-05 | 38 | 168 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 HIVEP1 ANPEP KDM5A ZGRF1 ZNF184 ZNF185 ZDBF2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 CREBBP RNF11 ZCCHC14 ERVK-8 ERVK-19 NR3C2 ERVK-24 PDZRN3 EP300 | 1.98e-05 | 891 | 168 | 21 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.59e-05 | 21 | 168 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 4.55e-05 | 112 | 168 | 7 | GO:0090079 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 7.04e-05 | 2 | 168 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | leukemia inhibitory factor receptor activity | 7.04e-05 | 2 | 168 | 2 | GO:0004923 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 7.04e-05 | 2 | 168 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 2.10e-04 | 3 | 168 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | oncostatin-M receptor activity | 2.10e-04 | 3 | 168 | 2 | GO:0004924 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.57e-04 | 37 | 168 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 USP10 CLCA2 LPA ERVK-8 ERVK-19 ERVK-24 SENP7 | 2.93e-04 | 430 | 168 | 12 | GO:0004175 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D15 STXBP5 ARHGEF5 RANBP3 DENND1C ANKRD27 ARHGAP31 RACGAP1 HERC1 DNMBP ARHGAP21 RIC1 FGD3 | 3.71e-04 | 507 | 168 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D15 STXBP5 ARHGEF5 RANBP3 DENND1C ANKRD27 ARHGAP31 RACGAP1 HERC1 DNMBP ARHGAP21 RIC1 FGD3 | 3.71e-04 | 507 | 168 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | ciliary neurotrophic factor receptor activity | 4.18e-04 | 4 | 168 | 2 | GO:0004897 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 5.99e-04 | 46 | 168 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | A2M PPP4R1 TBC1D15 KDM5A STXBP5 ARHGEF5 RANBP3 TOM1L1 CD109 WDR81 DENND1C WNK1 ANKRD27 CCND3 ARHGAP31 LPA SOCS5 RACGAP1 HERC1 DNMBP ARHGAP21 IL6ST RIC1 FGD3 | 8.11e-04 | 1418 | 168 | 24 | GO:0030234 |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 HIVEP1 ANPEP KDM5A ZGRF1 ZNF184 ZNF185 ZDBF2 ERVK-7 ERVK-21 ERVK-9 ERVK-10 CREBBP RNF11 ZCCHC14 ERVK-8 ERVK-19 NR3C2 ERVK-24 PDZRN3 EP300 | 1.04e-03 | 1189 | 168 | 21 | GO:0046914 |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 1.17e-03 | 25 | 168 | 3 | GO:0017056 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ANPEP USP25 ERVK-7 ERVK-21 ERVK-9 ERVK-10 USP10 CLCA2 LPA ERVK-8 ERVK-19 ERVK-24 SENP7 | 1.30e-03 | 654 | 168 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | potassium channel regulator activity | 1.35e-03 | 57 | 168 | 4 | GO:0015459 | |
| GeneOntologyMolecularFunction | ciliary neurotrophic factor receptor binding | 1.44e-03 | 7 | 168 | 2 | GO:0005127 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.73e-03 | 262 | 168 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.09e-03 | 156 | 168 | 6 | GO:0019838 | |
| GeneOntologyBiologicalProcess | female meiosis II | 2.27e-10 | 6 | 172 | 5 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 2.27e-10 | 6 | 172 | 5 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 2.27e-10 | 6 | 172 | 5 | GO:0061983 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 2.17e-06 | 26 | 172 | 5 | GO:0045836 | |
| GeneOntologyBiologicalProcess | DNA integration | 3.15e-06 | 13 | 172 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 3.84e-06 | 29 | 172 | 5 | GO:0045948 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 4.57e-06 | 52 | 172 | 6 | GO:0007143 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 5.42e-06 | 31 | 172 | 5 | GO:0070935 | |
| GeneOntologyBiologicalProcess | viral process | SELPLG ERVK-6 ANPEP ERVK-7 ERVK-21 ERVK-9 ERVK-10 ZDHHC8 CREBBP EIF2D EPHA2 ERVK-8 ERVK-19 ERVK-24 EP300 | 8.44e-06 | 464 | 172 | 15 | GO:0016032 |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 1.34e-05 | 37 | 172 | 5 | GO:0051446 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 3.55e-05 | 45 | 172 | 5 | GO:0040020 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 4.40e-05 | 47 | 172 | 5 | GO:0001556 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 4.87e-05 | 48 | 172 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 5.60e-05 | 307 | 172 | 11 | GO:0090068 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 7.82e-05 | 85 | 172 | 6 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 7.82e-05 | 85 | 172 | 6 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 1.01e-04 | 89 | 172 | 6 | GO:0006949 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 1.14e-04 | 91 | 172 | 6 | GO:0006446 | |
| GeneOntologyBiologicalProcess | translational initiation | 1.22e-04 | 132 | 172 | 7 | GO:0006413 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | TPR SGIP1 NEDD4L ATRX DAZ4 ARHGEF5 AMBRA1 DAZ1 DAZL WNK1 ANKRD27 PLEKHM1 GH1 PTPRD PTPRJ EPHA2 DDHD1 PAK1 AUTS2 SYT1 ROBO2 DAZ3 DAZ2 CAPRIN1 EP300 | 1.72e-04 | 1366 | 172 | 25 | GO:0051130 |
| GeneOntologyBiologicalProcess | positive regulation of translation | 2.80e-04 | 151 | 172 | 7 | GO:0045727 | |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | TPR ATRX DAZ4 ARHGEF5 AMBRA1 DAZ1 DAZL DDHD1 PAK1 SYT1 DAZ3 DAZ2 CAPRIN1 EP300 | 3.36e-04 | 574 | 172 | 14 | GO:0010638 |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 4.10e-04 | 75 | 172 | 5 | GO:0051785 | |
| GeneOntologyBiologicalProcess | oncostatin-M-mediated signaling pathway | 4.10e-04 | 4 | 172 | 2 | GO:0038165 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 4.10e-04 | 4 | 172 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | nuclear pore organization | 4.24e-04 | 18 | 172 | 3 | GO:0006999 | |
| HumanPheno | Supernumerary cusp | 9.89e-06 | 5 | 52 | 3 | HP:0033777 | |
| Domain | fn3 | 1.80e-06 | 162 | 165 | 10 | PF00041 | |
| Domain | LRRC37AB_C | 2.69e-06 | 4 | 165 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 2.69e-06 | 4 | 165 | 3 | PF14914 | |
| Domain | LRRC37_N | 2.69e-06 | 4 | 165 | 3 | IPR032754 | |
| Domain | LRRC37 | 2.69e-06 | 4 | 165 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 2.69e-06 | 4 | 165 | 3 | IPR015753 | |
| Domain | FN3 | 5.91e-06 | 185 | 165 | 10 | SM00060 | |
| Domain | FN3 | 1.12e-05 | 199 | 165 | 10 | PS50853 | |
| Domain | FN3_dom | 1.72e-05 | 209 | 165 | 10 | IPR003961 | |
| Domain | Nuc_rcpt_coact_CREBbp | 7.76e-05 | 2 | 165 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 7.76e-05 | 2 | 165 | 2 | SM00551 | |
| Domain | - | 7.76e-05 | 2 | 165 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 7.76e-05 | 2 | 165 | 2 | IPR010303 | |
| Domain | - | 7.76e-05 | 2 | 165 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 7.76e-05 | 2 | 165 | 2 | PF09030 | |
| Domain | zf-TAZ | 7.76e-05 | 2 | 165 | 2 | PF02135 | |
| Domain | ZF_TAZ | 7.76e-05 | 2 | 165 | 2 | PS50134 | |
| Domain | KAT11 | 7.76e-05 | 2 | 165 | 2 | SM01250 | |
| Domain | Znf_TAZ | 7.76e-05 | 2 | 165 | 2 | IPR000197 | |
| Domain | KIX | 7.76e-05 | 2 | 165 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 7.76e-05 | 2 | 165 | 2 | PF08214 | |
| Domain | KIX | 7.76e-05 | 2 | 165 | 2 | PS50952 | |
| Domain | CBP_P300_HAT | 7.76e-05 | 2 | 165 | 2 | IPR031162 | |
| Domain | DUF902 | 7.76e-05 | 2 | 165 | 2 | PF06001 | |
| Domain | - | 7.76e-05 | 2 | 165 | 2 | 1.10.246.20 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 7.76e-05 | 2 | 165 | 2 | IPR013178 | |
| Domain | KIX_dom | 7.76e-05 | 2 | 165 | 2 | IPR003101 | |
| Domain | CBP_P300_HAT | 7.76e-05 | 2 | 165 | 2 | PS51727 | |
| Domain | muHD | 2.31e-04 | 3 | 165 | 2 | PF10291 | |
| Domain | Muniscin_C | 2.31e-04 | 3 | 165 | 2 | IPR018808 | |
| Domain | PTPc | 2.78e-04 | 36 | 165 | 4 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 3.80e-04 | 39 | 165 | 4 | PS50055 | |
| Domain | PTPase_domain | 4.61e-04 | 41 | 165 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 4.61e-04 | 41 | 165 | 4 | PF00102 | |
| Domain | Tyr_Pase_AS | 4.69e-04 | 73 | 165 | 5 | IPR016130 | |
| Domain | TYR_PHOSPHATASE_1 | 9.91e-04 | 86 | 165 | 5 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 1.04e-03 | 87 | 165 | 5 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 1.04e-03 | 87 | 165 | 5 | PS50056 | |
| Domain | G_PATCH | 1.05e-03 | 23 | 165 | 3 | PS50174 | |
| Domain | G_patch | 1.05e-03 | 23 | 165 | 3 | SM00443 | |
| Domain | G_patch_dom | 1.05e-03 | 23 | 165 | 3 | IPR000467 | |
| Domain | G-patch | 1.05e-03 | 23 | 165 | 3 | PF01585 | |
| Domain | Nuc_rcpt_coact | 1.14e-03 | 6 | 165 | 2 | IPR009110 | |
| Domain | Hematopoietin_rcpt_Gp130_CS | 1.58e-03 | 7 | 165 | 2 | IPR003529 | |
| Domain | PDZ | 1.59e-03 | 141 | 165 | 6 | PF00595 | |
| Domain | DEATH | 1.69e-03 | 27 | 165 | 3 | SM00005 | |
| Domain | PTPc_motif | 1.83e-03 | 59 | 165 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.83e-03 | 59 | 165 | 4 | IPR003595 | |
| Domain | ANK_REPEAT | 1.88e-03 | 253 | 165 | 8 | PS50088 | |
| Domain | ANK_REP_REGION | 1.92e-03 | 254 | 165 | 8 | PS50297 | |
| Domain | PDZ | 2.04e-03 | 148 | 165 | 6 | SM00228 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 2.10e-03 | 8 | 165 | 2 | IPR019565 | |
| Domain | HEMATOPO_REC_L_F2 | 2.10e-03 | 8 | 165 | 2 | PS01353 | |
| Domain | Thiol-ester_cl | 2.10e-03 | 8 | 165 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 2.10e-03 | 8 | 165 | 2 | IPR019742 | |
| Domain | A2M_N_2 | 2.10e-03 | 8 | 165 | 2 | SM01359 | |
| Domain | - | 2.10e-03 | 8 | 165 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 2.10e-03 | 8 | 165 | 2 | SM01361 | |
| Domain | A2M | 2.10e-03 | 8 | 165 | 2 | SM01360 | |
| Domain | - | 2.18e-03 | 150 | 165 | 6 | 2.30.42.10 | |
| Domain | PDZ | 2.25e-03 | 151 | 165 | 6 | PS50106 | |
| Domain | PDZ | 2.33e-03 | 152 | 165 | 6 | IPR001478 | |
| Domain | RRM_1 | 2.54e-03 | 208 | 165 | 7 | PF00076 | |
| Domain | ZU5 | 2.68e-03 | 9 | 165 | 2 | SM00218 | |
| Domain | Death | 3.04e-03 | 33 | 165 | 3 | PF00531 | |
| Domain | RRM | 3.21e-03 | 217 | 165 | 7 | SM00360 | |
| Domain | A2M | 3.33e-03 | 10 | 165 | 2 | PF00207 | |
| Domain | A2M_N_2 | 3.33e-03 | 10 | 165 | 2 | IPR011625 | |
| Domain | A2M_comp | 3.33e-03 | 10 | 165 | 2 | IPR011626 | |
| Domain | A2M_recep | 3.33e-03 | 10 | 165 | 2 | PF07677 | |
| Domain | A2M_comp | 3.33e-03 | 10 | 165 | 2 | PF07678 | |
| Domain | A2M_N | 3.33e-03 | 10 | 165 | 2 | PF01835 | |
| Domain | A2M_N | 3.33e-03 | 10 | 165 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 3.33e-03 | 10 | 165 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 3.33e-03 | 10 | 165 | 2 | PS00477 | |
| Domain | ZU5 | 3.33e-03 | 10 | 165 | 2 | PS51145 | |
| Domain | Ank_3 | 3.33e-03 | 10 | 165 | 2 | PF13606 | |
| Domain | A2M_N_2 | 3.33e-03 | 10 | 165 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 3.33e-03 | 10 | 165 | 2 | IPR001599 | |
| Pathway | WP_OVARIAN_INFERTILITY | 7.43e-06 | 35 | 111 | 5 | MM15948 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | NEDD4L ATRX DAZ4 DAZ1 DAZL CREBBP LIFR DAZ3 DAZ2 EP300 IL6ST | 2.49e-05 | 301 | 111 | 11 | MM15983 |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 3.02e-05 | 155 | 111 | 8 | M41808 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 9.65e-05 | 94 | 111 | 6 | MM15598 | |
| Pathway | WP_MALE_INFERTILITY | 1.47e-04 | 145 | 111 | 7 | M39856 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.02e-04 | 15 | 111 | 3 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 2.02e-04 | 15 | 111 | 3 | M10183 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 2.22e-04 | 155 | 111 | 7 | M17411 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 4.20e-04 | 19 | 111 | 3 | M46442 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 4.63e-04 | 175 | 111 | 7 | MM15599 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 5.70e-04 | 21 | 111 | 3 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 5.70e-04 | 21 | 111 | 3 | M27485 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 6.05e-04 | 5 | 111 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 6.05e-04 | 5 | 111 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 6.05e-04 | 5 | 111 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 6.05e-04 | 5 | 111 | 2 | M27228 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 6.12e-04 | 87 | 111 | 5 | MM15600 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 6.24e-04 | 184 | 111 | 7 | M41809 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 6.44e-04 | 88 | 111 | 5 | M41810 | |
| Pathway | REACTOME_SUMOYLATION | 7.32e-04 | 189 | 111 | 7 | M27214 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 8.29e-04 | 93 | 111 | 5 | MM15609 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGEF5 WDR81 MTMR1 ARHGAP31 EPHA2 PAK1 RACGAP1 NHS DNMBP ARHGAP21 FGD3 | 8.32e-04 | 450 | 111 | 11 | M27078 |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 8.70e-04 | 94 | 111 | 5 | M41818 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 9.03e-04 | 6 | 111 | 2 | M22062 | |
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 23579190 | ||
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 20008336 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 3.41e-12 | 5 | 179 | 5 | 8679003 | |
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 22293198 | ||
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 11089564 | ||
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 3.41e-12 | 5 | 179 | 5 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 3.41e-12 | 5 | 179 | 5 | 8968756 | |
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 3.41e-12 | 5 | 179 | 5 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 3.41e-12 | 5 | 179 | 5 | 26411291 | |
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 34985827 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 3.41e-12 | 5 | 179 | 5 | 14648873 | |
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 8896558 | ||
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 9700189 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 3.41e-12 | 5 | 179 | 5 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 3.41e-12 | 5 | 179 | 5 | 9288969 | |
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 23456578 | ||
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 3.41e-12 | 5 | 179 | 5 | 10903443 | |
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 3.41e-12 | 5 | 179 | 5 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 3.41e-12 | 5 | 179 | 5 | 8845845 | |
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 11058556 | ||
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 3.41e-12 | 5 | 179 | 5 | 19783541 | |
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 17761180 | ||
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 3.41e-12 | 5 | 179 | 5 | 12200456 | |
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 11514340 | ||
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 3.41e-12 | 5 | 179 | 5 | 22223682 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 3.41e-12 | 5 | 179 | 5 | 23223451 | |
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 11804965 | ||
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 21270429 | ||
| Pubmed | 3.41e-12 | 5 | 179 | 5 | 8661148 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 2.04e-11 | 6 | 179 | 5 | 18452650 | |
| Pubmed | 2.04e-11 | 6 | 179 | 5 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 2.04e-11 | 6 | 179 | 5 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 2.04e-11 | 6 | 179 | 5 | 31355046 | |
| Pubmed | 2.04e-11 | 6 | 179 | 5 | 20157580 | ||
| Pubmed | 2.04e-11 | 6 | 179 | 5 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 2.04e-11 | 6 | 179 | 5 | 26077710 | |
| Pubmed | 2.04e-11 | 6 | 179 | 5 | 17526644 | ||
| Pubmed | 2.04e-11 | 6 | 179 | 5 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 2.04e-11 | 6 | 179 | 5 | 14611632 | |
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 2.04e-11 | 6 | 179 | 5 | 15066460 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 2.04e-11 | 6 | 179 | 5 | 23417416 | |
| Pubmed | 2.04e-11 | 6 | 179 | 5 | 32170089 | ||
| Pubmed | 2.04e-11 | 6 | 179 | 5 | 16278232 | ||
| Pubmed | 2.04e-11 | 6 | 179 | 5 | 17219433 | ||
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 2.04e-11 | 6 | 179 | 5 | 16001084 | |
| Pubmed | 2.04e-11 | 6 | 179 | 5 | 32962040 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 2.04e-11 | 6 | 179 | 5 | 1869307 | |
| Pubmed | 2.04e-11 | 6 | 179 | 5 | 11390979 | ||
| Pubmed | 2.04e-11 | 6 | 179 | 5 | 27632217 | ||
| Pubmed | Epigenetic functions of smchd1 repress gene clusters on the inactive X chromosome and on autosomes. | 2.08e-11 | 59 | 179 | 9 | 23754746 | |
| Pubmed | 7.11e-11 | 7 | 179 | 5 | 15081113 | ||
| Pubmed | 7.11e-11 | 7 | 179 | 5 | 22699423 | ||
| Pubmed | 7.11e-11 | 7 | 179 | 5 | 11604102 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 7.11e-11 | 7 | 179 | 5 | 16946704 | |
| Pubmed | 7.11e-11 | 7 | 179 | 5 | 10857750 | ||
| Pubmed | 7.11e-11 | 7 | 179 | 5 | 11410654 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 7.11e-11 | 7 | 179 | 5 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 7.11e-11 | 7 | 179 | 5 | 26826184 | |
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 1.89e-10 | 8 | 179 | 5 | 23204224 | |
| Pubmed | 1.89e-10 | 8 | 179 | 5 | 29883445 | ||
| Pubmed | 1.89e-10 | 8 | 179 | 5 | 10823932 | ||
| Pubmed | 1.89e-10 | 8 | 179 | 5 | 10951504 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 1.89e-10 | 8 | 179 | 5 | 32339196 | |
| Pubmed | 1.89e-10 | 8 | 179 | 5 | 33749946 | ||
| Pubmed | 1.89e-10 | 8 | 179 | 5 | 22621333 | ||
| Pubmed | 1.89e-10 | 8 | 179 | 5 | 32686646 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 4.23e-10 | 9 | 179 | 5 | 16310179 | |
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 4.23e-10 | 9 | 179 | 5 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 4.23e-10 | 9 | 179 | 5 | 19695304 | |
| Pubmed | 4.23e-10 | 9 | 179 | 5 | 28235998 | ||
| Pubmed | 4.23e-10 | 9 | 179 | 5 | 20159962 | ||
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 7670487 | ||
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 11694340 | ||
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 9321470 | ||
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 19223287 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 6.79e-10 | 4 | 179 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 6.79e-10 | 4 | 179 | 4 | 11688365 | |
| Pubmed | 6.79e-10 | 4 | 179 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 6.79e-10 | 4 | 179 | 4 | 11883873 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 6.79e-10 | 4 | 179 | 4 | 12801575 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 6.79e-10 | 4 | 179 | 4 | 15066457 | |
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 6.79e-10 | 4 | 179 | 4 | 11095434 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.79e-10 | 4 | 179 | 4 | 10469592 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 6.79e-10 | 4 | 179 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 6.79e-10 | 4 | 179 | 4 | 16963411 | |
| Pubmed | 8.43e-10 | 10 | 179 | 5 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 8.43e-10 | 10 | 179 | 5 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 8.43e-10 | 10 | 179 | 5 | 38433229 | |
| Pubmed | 8.43e-10 | 10 | 179 | 5 | 23810942 | ||
| Pubmed | 8.43e-10 | 10 | 179 | 5 | 12837688 | ||
| Pubmed | 8.43e-10 | 10 | 179 | 5 | 10601091 | ||
| Pubmed | 8.43e-10 | 10 | 179 | 5 | 9922113 | ||
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 1.54e-09 | 11 | 179 | 5 | 34401671 | |
| Pubmed | HAUS5 AMBRA1 INPP5F SLC7A6 LRCH1 ANKRD27 USP10 ARHGAP31 ZC3H4 SULF1 DDHD1 MDC1 AUTS2 RACGAP1 ROBO2 NUP93 DNMBP | 2.56e-09 | 529 | 179 | 17 | 14621295 | |
| Pubmed | 2.63e-09 | 12 | 179 | 5 | 32054698 | ||
| Pubmed | Germ cell-intrinsic and -extrinsic factors govern meiotic initiation in mouse embryos. | 2.63e-09 | 12 | 179 | 5 | 19074348 | |
| GeneFamily | Fibronectin type III domain containing | 1.12e-07 | 160 | 120 | 10 | 555 | |
| GeneFamily | CTAGE family | 1.22e-04 | 15 | 120 | 3 | 907 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.48e-04 | 21 | 120 | 3 | 813 | |
| GeneFamily | CD molecules|Mucins | 3.48e-04 | 21 | 120 | 3 | 648 | |
| GeneFamily | PDZ domain containing | 5.32e-04 | 152 | 120 | 6 | 1220 | |
| GeneFamily | RNA binding motif containing | 5.51e-04 | 213 | 120 | 7 | 725 | |
| GeneFamily | Ankyrin repeat domain containing | 1.17e-03 | 242 | 120 | 7 | 403 | |
| GeneFamily | Nucleoporins | 1.23e-03 | 32 | 120 | 3 | 1051 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.53e-03 | 9 | 120 | 2 | 1234 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.57e-03 | 17 | 120 | 2 | 486 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 6.24e-03 | 18 | 120 | 2 | 498 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.24e-03 | 18 | 120 | 2 | 91 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 8.02e-09 | 12 | 169 | 5 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 8.02e-09 | 12 | 169 | 5 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 3.22e-07 | 23 | 169 | 5 | MM1293 | |
| Coexpression | GSE20366_TREG_VS_TCONV_UP | 7.45e-07 | 200 | 169 | 10 | M4311 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.06e-06 | 208 | 169 | 10 | M39233 | |
| Coexpression | MATZUK_SPERMATOGONIA | 1.56e-06 | 31 | 169 | 5 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 2.15e-06 | 33 | 169 | 5 | MM701 | |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 2.23e-06 | 131 | 169 | 8 | M39232 | |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 4.45e-06 | 244 | 169 | 10 | M40312 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.42e-05 | 221 | 169 | 9 | M39222 | |
| Coexpression | LAKE_ADULT_KIDNEY_C28_INTERSTITIUM | 2.02e-05 | 86 | 169 | 6 | M39247 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | ATRX KDM5A BACH1 CREBBP CEP350 ZCCHC14 ZC3H4 MDC1 AUTS2 NPAT | 2.68e-05 | 300 | 169 | 10 | M8702 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 3.11e-05 | 137 | 169 | 7 | M39241 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 3.15e-05 | 93 | 169 | 6 | MM1185 | |
| Coexpression | SENESE_HDAC1_TARGETS_UP | TPR NEDD4L BACH1 MTMR1 ITPRID2 SLC7A6 PLEKHM1 USP10 ZNF644 KIAA1217 CAPRIN1 IL6ST | 3.88e-05 | 451 | 169 | 12 | M14973 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP1 SGIP1 ATXN7L1 ZNF185 USP25 APBB2 MCC ITPRID2 LRCH1 CREBBP DCAF5 RNF11 LIFR PTPRJ ARHGAP31 EP300 IL6ST | 4.02e-05 | 854 | 169 | 17 | M1533 |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 4.08e-05 | 195 | 169 | 8 | M7310 | |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 4.88e-05 | 200 | 169 | 8 | M8032 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIVEP1 SGIP1 ATXN7L1 ZNF185 USP25 APBB2 MCC ITPRID2 LRCH1 CREBBP DCAF5 RNF11 LIFR PTPRJ ARHGAP31 EP300 IL6ST | 6.50e-05 | 888 | 169 | 17 | MM1018 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SELPLG TPR ATRX SPN KDM5A USP25 FXYD5 DENND1C SLC7A6 WNK1 CREBBP DCAF5 CCND3 CEP350 PTPN4 PTPRJ ZNF644 AUTS2 HERC1 EP300 FGD3 SENP7 NPAT | 9.31e-05 | 1492 | 169 | 23 | M40023 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | ANK2 OLFML2B STXBP5 APBB2 MCC WNK1 CREBBP DCAF5 RNF11 PTPRD ZNF644 KIAA1217 ZNF483 FAM217B AUTS2 CHD6 CAPRIN1 PDZRN3 | 9.64e-05 | 1009 | 169 | 18 | M157 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.56e-04 | 177 | 169 | 7 | M39245 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | TBC1D15 ZBTB20 ATRX BACH1 PCDHB11 DAZL INPP5F CREBBP ZCCHC14 LIFR ADGRG2 RBMS3 ARHGAP31 KIAA1217 RLIM RBM5 ROBO2 HERC1 RNF182 SENP7 | 5.70e-06 | 801 | 168 | 20 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | HIVEP1 ZNF184 BACH1 MCC MUC16 ZDBF2 CEP350 LIFR PTPN4 CLCA2 RBMS3 SULF1 KIAA1217 RLIM ZNF483 ROBO2 LRRN4 PDZRN3 RNF182 | 3.35e-05 | 831 | 168 | 19 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | A2M PCDHB12 PCDHB11 CD109 MCC LIFR RBMS3 ARHGAP31 SULF1 ALPK3 SYT1 GPR176 PDZD2 | 3.55e-13 | 185 | 170 | 13 | fa94c4a1660967f211ba095606cd0aa37d38e17a |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | A2M PCDHB12 PCDHB11 CD109 MCC LIFR RBMS3 ARHGAP31 SULF1 ALPK3 GPR176 PDZD2 | 8.60e-12 | 187 | 170 | 12 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | A2M PCDHB12 PCDHB11 CD109 MCC LIFR RBMS3 ARHGAP31 SULF1 ALPK3 GPR176 PDZD2 | 8.60e-12 | 187 | 170 | 12 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | ZBTB20 NEDD4L ANK3 LRRC37A3 ANKS1B APBB2 AMBRA1 PTPRD PTPRJ AUTS2 NR3C2 PDZD2 | 1.49e-11 | 196 | 170 | 12 | ab53c742866945545a92e2e61850d63c80d9a2a6 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | ZBTB20 ANK3 LRRC37A3 STXBP5 USP25 APBB2 AMBRA1 PTPRJ AUTS2 NR3C2 HERC1 | 3.21e-10 | 199 | 170 | 11 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.79e-09 | 178 | 170 | 10 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | LRRC37A3 OLFML2B SLC7A6 ANKRD27 ZCCHC14 ZNF469 SULF1 FAM217B CHD6 DNMBP | 3.04e-09 | 188 | 170 | 10 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.76e-09 | 197 | 170 | 10 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | ZBTB20 NEDD4L ANK3 LRRC37A3 APBB2 AMBRA1 PTPRD AUTS2 NR3C2 PDZD2 | 5.00e-09 | 198 | 170 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 3.42e-08 | 181 | 170 | 9 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.32e-08 | 186 | 170 | 9 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-08 | 191 | 170 | 9 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-08 | 191 | 170 | 9 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | ANK2 LRRC37A3 ANKS1B APBB2 SLC7A6 KIAA1217 AUTS2 SYT1 PDZRN3 | 5.67e-08 | 192 | 170 | 9 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-08 | 196 | 170 | 9 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-08 | 196 | 170 | 9 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 3.35e-07 | 172 | 170 | 8 | 0657c736f3c52d25cf7f652eac005ddcde9232ef | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 3.66e-07 | 174 | 170 | 8 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-07 | 176 | 170 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 5.37e-07 | 183 | 170 | 8 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 5.37e-07 | 183 | 170 | 8 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.85e-07 | 189 | 170 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-07 | 190 | 170 | 8 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-07 | 190 | 170 | 8 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.13e-07 | 190 | 170 | 8 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.42e-07 | 191 | 170 | 8 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.42e-07 | 191 | 170 | 8 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-07 | 192 | 170 | 8 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.71e-07 | 192 | 170 | 8 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 8.02e-07 | 193 | 170 | 8 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 9.01e-07 | 196 | 170 | 8 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-07 | 196 | 170 | 8 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 9.36e-07 | 197 | 170 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.01e-06 | 199 | 170 | 8 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.70e-06 | 167 | 170 | 7 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.85e-06 | 168 | 170 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.43e-06 | 177 | 170 | 7 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.43e-06 | 177 | 170 | 7 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 5.84e-06 | 179 | 170 | 7 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-06 | 180 | 170 | 7 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.06e-06 | 180 | 170 | 7 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-06 | 180 | 170 | 7 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.06e-06 | 180 | 170 | 7 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 6.51e-06 | 182 | 170 | 7 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 6.51e-06 | 182 | 170 | 7 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.75e-06 | 183 | 170 | 7 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.75e-06 | 183 | 170 | 7 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-06 | 185 | 170 | 7 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 7.25e-06 | 185 | 170 | 7 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 7.78e-06 | 187 | 170 | 7 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.05e-06 | 188 | 170 | 7 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-T_cells-Activated_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.33e-06 | 189 | 170 | 7 | 1a891ae8517086fcf6443660976aef6413fa79ae | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.63e-06 | 190 | 170 | 7 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 8.63e-06 | 190 | 170 | 7 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.63e-06 | 190 | 170 | 7 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 8.63e-06 | 190 | 170 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.93e-06 | 191 | 170 | 7 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.93e-06 | 191 | 170 | 7 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.23e-06 | 192 | 170 | 7 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.23e-06 | 192 | 170 | 7 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 9.23e-06 | 192 | 170 | 7 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-06 | 192 | 170 | 7 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-06 | 192 | 170 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.55e-06 | 193 | 170 | 7 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-22|World / Primary Cells by Cluster | 9.55e-06 | 193 | 170 | 7 | 3b927d4b8ecb21a408424ef91a23746c21741f49 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.88e-06 | 194 | 170 | 7 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.88e-06 | 194 | 170 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.88e-06 | 194 | 170 | 7 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.88e-06 | 194 | 170 | 7 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 195 | 170 | 7 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-05 | 195 | 170 | 7 | c6bb16c0076639c6ddef1a15d8cba44bc29c077d | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.02e-05 | 195 | 170 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-05 | 195 | 170 | 7 | ea89f80d3d7e9f737442f7c1aa1791d277ffc90c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 195 | 170 | 7 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 196 | 170 | 7 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41|World / Primary Cells by Cluster | 1.06e-05 | 196 | 170 | 7 | dee0984cd63a1a2fdebb4421af48ab566a5b684e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.09e-05 | 197 | 170 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-05 | 197 | 170 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | T_cells-Treg_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.09e-05 | 197 | 170 | 7 | ec9398ae3577f61d6b1e6aba50ef4261aaaa7610 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 197 | 170 | 7 | 5fbbc570a4e77c703f569a4f85ce2d8af67d6297 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 198 | 170 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 198 | 170 | 7 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.13e-05 | 198 | 170 | 7 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.17e-05 | 199 | 170 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.17e-05 | 199 | 170 | 7 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.17e-05 | 199 | 170 | 7 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-05 | 200 | 170 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-05 | 200 | 170 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.20e-05 | 200 | 170 | 7 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.20e-05 | 200 | 170 | 7 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-05 | 200 | 170 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.20e-05 | 200 | 170 | 7 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.20e-05 | 200 | 170 | 7 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | Adult-Epithelial-basal_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.72e-05 | 153 | 170 | 6 | 9ee3e7f3f19a2474283c1c79045269686f35a541 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 156 | 170 | 6 | d72c2f5f72d269e29033f8728d924e0d4c8772c7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.14e-05 | 157 | 170 | 6 | a633fb8e7a009490c6002bf272eceaf317f27af6 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.14e-05 | 157 | 170 | 6 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 161 | 170 | 6 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.74e-05 | 162 | 170 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|normal_Lung / Location, Cell class and cell subclass | 4.29e-05 | 166 | 170 | 6 | ff32422390852546e0cb216192452e9c47bd9509 | |
| Drug | AZFd | 1.34e-08 | 23 | 168 | 6 | CID000196489 | |
| Drug | boron trichloride | 4.24e-08 | 6 | 168 | 4 | CID000025135 | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.96e-06 | 195 | 168 | 10 | 6159_DN | |
| Drug | azafagomine | 3.92e-06 | 57 | 168 | 6 | CID011957435 | |
| Drug | desmethylazelastine | 4.86e-06 | 16 | 168 | 4 | CID000162558 | |
| Drug | Vistar | 6.46e-06 | 36 | 168 | 5 | CID000040896 | |
| Drug | 3-bromo-7-nitroindazole | 6.46e-06 | 36 | 168 | 5 | CID000001649 | |
| Drug | dazmegrel | 1.02e-05 | 19 | 168 | 4 | CID000053555 | |
| Drug | YM 026 | 1.02e-05 | 19 | 168 | 4 | CID000004443 | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.45e-05 | 194 | 168 | 9 | 4281_DN | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 1.51e-05 | 195 | 168 | 9 | 3504_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 1.77e-05 | 199 | 168 | 9 | 6942_DN | |
| Drug | Gleevec; Down 200; 10uM; MCF7; HG-U133A | 1.77e-05 | 199 | 168 | 9 | 366_DN | |
| Drug | p11-13 | 1.95e-05 | 75 | 168 | 6 | CID000015759 | |
| Drug | dansylaziridine | 2.27e-05 | 23 | 168 | 4 | CID000104008 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 4.66e-05 | 174 | 168 | 8 | 7530_DN | |
| Disease | Male sterility due to Y-chromosome deletions | 6.17e-08 | 8 | 163 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 6.17e-08 | 8 | 163 | 4 | C1507149 | |
| Disease | QRS amplitude, QRS complex | 8.38e-06 | 50 | 163 | 5 | EFO_0005054, EFO_0007742 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 3.03e-05 | 2 | 163 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 3.03e-05 | 2 | 163 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 3.03e-05 | 2 | 163 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 3.03e-05 | 2 | 163 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 3.03e-05 | 2 | 163 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 3.03e-05 | 2 | 163 | 2 | C4551859 | |
| Disease | Stuve-Wiedemann syndrome | 3.03e-05 | 2 | 163 | 2 | cv:C0796176 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 3.03e-05 | 2 | 163 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 3.03e-05 | 2 | 163 | 2 | C0035934 | |
| Disease | bone mineral content measurement | 8.78e-05 | 130 | 163 | 6 | EFO_0007621 | |
| Disease | Congenital total cataract | 8.79e-05 | 16 | 163 | 3 | C0266539 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 8.79e-05 | 16 | 163 | 3 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 8.79e-05 | 16 | 163 | 3 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 8.79e-05 | 16 | 163 | 3 | 415000 | |
| Disease | Schwartz-Jampel syndrome | 9.07e-05 | 3 | 163 | 2 | cv:C0036391 | |
| Disease | post-traumatic stress disorder symptom measurement | 9.36e-05 | 82 | 163 | 5 | EFO_0008535 | |
| Disease | Colorectal Carcinoma | ANK2 CD109 MCC WNK1 LIFR PTPRD NR3C2 CDH7 EP300 RNF182 IL6ST GABPB1 RIC3 | 1.51e-04 | 702 | 163 | 13 | C0009402 |
| Disease | obsolete_red blood cell distribution width | HBS1L ASDURF BACH1 LRRC37A2 WNK1 LRCH1 SLC40A1 GMNN ANKRD27 CCND3 PTPRH MUC17 ZC3H4 KIAA1217 ZBTB40 HERC1 ARHGAP21 EP300 RNF182 | 1.72e-04 | 1347 | 163 | 19 | EFO_0005192 |
| Disease | Congenital myotonia | 1.81e-04 | 4 | 163 | 2 | cv:CN295225 | |
| Disease | Acute Cerebrovascular Accidents | 2.29e-04 | 54 | 163 | 4 | C0751956 | |
| Disease | glucose measurement | ZBTB20 SGIP1 LRRC37A3 ENTHD1 LRRC37A PTPRJ ZC3H4 AUTS2 HERC1 | 2.78e-04 | 380 | 163 | 9 | EFO_0004468 |
| Disease | Malignant neoplasm of breast | ANK2 LRRC37A2 CD109 COG3 WNK1 ZCCHC14 LRRC37A PTPRD CLCA2 ZNF644 PAK1 FAM217B NHS EP300 RNF182 TP53BP2 | 3.16e-04 | 1074 | 163 | 16 | C0006142 |
| Disease | insulin resistance | 3.22e-04 | 59 | 163 | 4 | EFO_0002614 | |
| Disease | Cerebrovascular accident | 3.90e-04 | 62 | 163 | 4 | C0038454 | |
| Disease | Colorectal cancer | 4.39e-04 | 27 | 163 | 3 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 4.39e-04 | 27 | 163 | 3 | 114500 | |
| Disease | Neoplasm of the large intestine | 4.39e-04 | 27 | 163 | 3 | cv:C0009404 | |
| Disease | parental longevity | ANK2 ATXN7L1 ANKRD27 CEP350 PTPRD RBMS3 LPA ROBO2 MUC22 GPANK1 | 4.45e-04 | 494 | 163 | 10 | EFO_0007796 |
| Disease | JT interval | 4.77e-04 | 248 | 163 | 7 | EFO_0007885 | |
| Disease | white matter volume measurement | 7.30e-04 | 32 | 163 | 3 | EFO_0008320 | |
| Disease | wellbeing measurement, alcohol consumption measurement | 7.64e-04 | 74 | 163 | 4 | EFO_0007869, EFO_0007878 | |
| Disease | QT interval | SGIP1 OLFML2B BACH1 LRCH1 CREBBP PTPRJ ALPK3 NR3C2 ARHGAP21 PDZRN3 | 8.10e-04 | 534 | 163 | 10 | EFO_0004682 |
| Disease | pseudohypoaldosteronism (is_implicated_in) | 8.31e-04 | 8 | 163 | 2 | DOID:4479 (is_implicated_in) | |
| Disease | cognitive function measurement | PPP4R1 PCBP3 HIVEP1 NEDD4L ZNF184 ENTHD1 ZDBF2 BARX2 COG3 SLC7A6 PLEKHM1 ZCCHC14 PTPRD KIAA1217 AUTS2 SYT1 CDH7 ARHGAP21 | 1.01e-03 | 1434 | 163 | 18 | EFO_0008354 |
| Disease | Growth Disorders | 1.03e-03 | 36 | 163 | 3 | C0018273 | |
| Disease | PITUITARY DWARFISM I | 1.06e-03 | 9 | 163 | 2 | C0342573 | |
| Disease | otosclerosis | 1.07e-03 | 81 | 163 | 4 | EFO_0004213 | |
| Disease | serum alanine aminotransferase measurement | NEDD4L ANPEP BACH1 BARX2 CMYA5 DCAF5 PTPRJ RBMS3 ZC3H4 EPHA2 DNMBP SENP7 TJP3 | 1.12e-03 | 869 | 163 | 13 | EFO_0004735 |
| Disease | Hodgkins lymphoma | 1.12e-03 | 82 | 163 | 4 | EFO_0000183 | |
| Disease | short-term memory | 1.17e-03 | 83 | 163 | 4 | EFO_0004335 | |
| Disease | Pseudohypoaldosteronism, Type I | 1.33e-03 | 10 | 163 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 1.33e-03 | 10 | 163 | 2 | C0033805 | |
| Disease | beta thalassemia (is_implicated_in) | 1.33e-03 | 10 | 163 | 2 | DOID:12241 (is_implicated_in) | |
| Disease | Hyperpotassemia and Hypertension, Familial | 1.33e-03 | 10 | 163 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 1.33e-03 | 10 | 163 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 1.33e-03 | 10 | 163 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 1.33e-03 | 10 | 163 | 2 | C1449842 | |
| Disease | Carcinoma, Transitional Cell | 1.51e-03 | 41 | 163 | 3 | C0007138 | |
| Disease | alkaline phosphatase measurement | ZBTB20 NEDD4L WDR81 PLEKHM1 POM121 PTPRJ ZBTB40 IZUMO1 NR3C2 LTBP3 MUC22 ARHGAP21 RIC1 SENP7 | 1.56e-03 | 1015 | 163 | 14 | EFO_0004533 |
| Disease | aspartate aminotransferase measurement | HBS1L NEDD4L ANPEP ZPLD1 BACH1 INPP5F PLEKHM1 PTPRD PTPRJ RBMS3 MYO15A DNMBP TJP3 | 1.59e-03 | 904 | 163 | 13 | EFO_0004736 |
| Disease | serum gamma-glutamyl transferase measurement | SGIP1 NEDD4L ATRX BACH1 MCC FCHO1 DCAF5 POM121 RBMS3 EPHA2 DNMBP ARHGAP21 TJP3 | 1.76e-03 | 914 | 163 | 13 | EFO_0004532 |
| Disease | Mitral valve prolapse, response to surgery | 1.93e-03 | 12 | 163 | 2 | EFO_0009951, HP_0001634 | |
| Disease | Dental enamel hypoplasia | 1.93e-03 | 12 | 163 | 2 | EFO_1001304 | |
| Disease | interleukin 17 measurement | 1.98e-03 | 45 | 163 | 3 | EFO_0008174 | |
| Disease | Modic type vertebral endplate changes | 2.27e-03 | 13 | 163 | 2 | HP_0030775 | |
| Disease | smoking cessation | 2.27e-03 | 325 | 163 | 7 | EFO_0004319 | |
| Disease | Prostatic Neoplasms | ZBTB20 ARHGEF5 TOM1L1 CREBBP LIFR RLIM ROBO2 CHD6 IL6ST TJP3 | 2.33e-03 | 616 | 163 | 10 | C0033578 |
| Disease | Malignant neoplasm of prostate | ZBTB20 ARHGEF5 TOM1L1 CREBBP LIFR RLIM ROBO2 CHD6 IL6ST TJP3 | 2.33e-03 | 616 | 163 | 10 | C0376358 |
| Disease | phosphoglycerides measurement | 2.39e-03 | 48 | 163 | 3 | EFO_0022291 | |
| Disease | restless legs syndrome | 2.53e-03 | 49 | 163 | 3 | EFO_0004270 | |
| Disease | handedness | 2.88e-03 | 106 | 163 | 4 | EFO_0009902 | |
| Disease | forehead morphology measurement | 3.04e-03 | 15 | 163 | 2 | EFO_0007844 | |
| Disease | response to olanzapine | 3.04e-03 | 15 | 163 | 2 | GO_0097333 | |
| Disease | third ventricle volume measurement | 3.04e-03 | 15 | 163 | 2 | EFO_0010335 | |
| Disease | lymphocyte count | HBS1L HIVEP1 CPXCR1 GH1 CCND3 PTPN4 ZNF469 PTPRH PTPRJ ARHGAP31 ZNF644 AUTS2 ROBO2 NR3C2 LTBP3 MUC22 PCDHGC3 | 3.13e-03 | 1464 | 163 | 17 | EFO_0004587 |
| Disease | platelet component distribution width | HBS1L FXYD5 WNK1 LRCH1 DCAF5 CCND3 PTPRH DDHD1 NR3C2 HERC1 FGD3 | 3.28e-03 | 755 | 163 | 11 | EFO_0007984 |
| Disease | Small cell carcinoma of lung | 3.34e-03 | 54 | 163 | 3 | C0149925 | |
| Disease | myocardial infarction | 3.42e-03 | 350 | 163 | 7 | EFO_0000612 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 3.46e-03 | 16 | 163 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | factor VIII measurement, coronary artery disease | 3.62e-03 | 113 | 163 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | cognitive function measurement, self reported educational attainment | 3.70e-03 | 355 | 163 | 7 | EFO_0004784, EFO_0008354 | |
| Disease | heart failure | 3.73e-03 | 185 | 163 | 5 | EFO_0003144 | |
| Disease | dental caries | 3.90e-03 | 187 | 163 | 5 | EFO_0003819 | |
| Disease | MHPG measurement, 5-HIAA measurement | 3.91e-03 | 17 | 163 | 2 | EFO_0005132, EFO_0005133 | |
| Disease | diastolic blood pressure, systolic blood pressure | 4.22e-03 | 670 | 163 | 10 | EFO_0006335, EFO_0006336 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 4.23e-03 | 118 | 163 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | neuroticism measurement, cognitive function measurement | 4.36e-03 | 566 | 163 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | Nuclear non-senile cataract | 4.38e-03 | 18 | 163 | 2 | C1112705 | |
| Disease | Nuclear cataract | 4.38e-03 | 18 | 163 | 2 | C0392557 | |
| Disease | retinal layer thickness measurement | 4.50e-03 | 60 | 163 | 3 | EFO_0600002 | |
| Disease | Colorectal Neoplasms | 4.51e-03 | 277 | 163 | 6 | C0009404 | |
| Disease | response to opioid | 4.71e-03 | 61 | 163 | 3 | EFO_0008541 | |
| Disease | cerebral infarction (is_marker_for) | 4.88e-03 | 19 | 163 | 2 | DOID:3526 (is_marker_for) | |
| Disease | lean body mass | 5.26e-03 | 379 | 163 | 7 | EFO_0004995 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PNLSTVSQIDPSSIE | 451 | Q09472 | |
| PEPGQRTFTTLSSVN | 446 | O14867 | |
| SPTSQTIQEGSREQP | 361 | P41214 | |
| SGTTDVTNRNSPATP | 21 | Q92870 | |
| QGPSQTSTPTDVTAI | 276 | P30281 | |
| PSDTGSLSSPVEQDR | 591 | Q8IX94 | |
| PSDTGSLSSPVEQDR | 591 | P0CG41 | |
| PSDTGSLSSPVEQDR | 591 | A4FU28 | |
| SSRNTQTLESNPSPE | 316 | A6NCI8 | |
| SQQRLESLSETPGPS | 1111 | Q12774 | |
| PSSNGTPEVETTSLN | 61 | Q8IZP9 | |
| SEQEVATSLGPPSRT | 926 | Q96L96 | |
| RVPTPSSVASAETNS | 971 | Q92793 | |
| PTSDPTEVVNGISSQ | 401 | Q6XZF7 | |
| STPASEINTPAQISE | 456 | P15144 | |
| VGEQSTVQDSATPSP | 256 | Q9C0C7 | |
| TQTEREVPEPGTAAS | 1116 | Q9C0C7 | |
| TLSERPSPSTDVQTD | 106 | Q96DB9 | |
| QLIPSESDQEVTSPS | 641 | Q8IV53 | |
| QEPVARPSGASSSQT | 11 | Q8NBA8 | |
| PSTPESREKTSGATQ | 251 | Q8N5S3 | |
| PETPNSTISREASTQ | 6 | Q13117 | |
| PETPNSTISREASTQ | 6 | Q9NR90 | |
| QPEATQVPLVSSTSE | 426 | Q14444 | |
| SVTASSESPVEIQNP | 776 | Q13625 | |
| TRPEDSSVLIPTDNS | 6 | L0R819 | |
| TSTREILPSQSGPAQ | 356 | Q9ULK2 | |
| PAPTSEDLTSATNIV | 1221 | P01023 | |
| TNPINREPGTATSQE | 46 | Q8N123 | |
| TSPSSSSRPQRVIED | 766 | Q8N1F7 | |
| TAGSRQPSVETLDSP | 36 | Q13613 | |
| SLTQFPPSQSEERSS | 126 | Q9H6Z4 | |
| TPPSESQLVDTGTQT | 346 | Q9UPQ7 | |
| VADTSPQTVAPSSQD | 396 | Q6XE24 | |
| TPEQTSPRAEESRGS | 1366 | Q4ADV7 | |
| TSPSEVFVNQRSPSS | 426 | P29074 | |
| TIQASEEQSSTPAPV | 221 | Q9Y450 | |
| SPRAQTITDTPITQE | 231 | Q2M2E3 | |
| QVTRPSGQISDPSRS | 156 | Q14207 | |
| VDRQSQGTTPDTTPA | 3071 | Q01484 | |
| PVQSPQRSVDSISQE | 631 | Q96NW4 | |
| SPRTDNASEVAVTTP | 476 | Q7Z6G8 | |
| PTLSENSPSGQRDVS | 281 | Q8IYW4 | |
| TVRPDVTQNSTAEPS | 326 | O14526 | |
| PTTNTETSIPVNSAG | 2211 | Q8WXI7 | |
| DRPQVPTSTTETNTA | 2411 | Q8WXI7 | |
| GENPTSSNSVVTSVP | 2486 | Q8WXI7 | |
| SNILEDPVTSPNSVS | 3366 | Q8WXI7 | |
| PVDPSSGQQSRDTEV | 316 | Q12913 | |
| PSESSREVESSPTQQ | 366 | O60309 | |
| REVESSPTQQETPGQ | 371 | O60309 | |
| GSSTLRDVVPSPDTQ | 351 | P08235 | |
| QPVTSEPTSQVTRGR | 1176 | Q14676 | |
| DRPVTSEPTSQATRG | 1216 | Q14676 | |
| VPTAPELQISTSTDQ | 1326 | Q14676 | |
| LQASASTDQPVTSEP | 1496 | Q14676 | |
| SDASIPQESQGVSPT | 56 | Q8N7X4 | |
| RVATPQVSGEDTQPT | 136 | Q96JG8 | |
| ESTKSSNVPRGQPSD | 336 | Q6NUN7 | |
| REVESSPTQQETPGQ | 371 | A6NM11 | |
| REVESSPTQQETPGQ | 371 | A6NMS7 | |
| TPSLEISSNNQERPT | 51 | Q8NA97 | |
| ESSAPDSQRSQTEPA | 51 | O95872 | |
| SAPPLSTVDSVSQVA | 421 | Q14439 | |
| TSTNASTVPFRNPDE | 236 | P16150 | |
| TREPTSSTFQETGPV | 1621 | E2RYF6 | |
| VLAQDQASPETTSPS | 2541 | Q9UKN7 | |
| AQPPVLVSGNDTSSR | 1676 | Q5HYC2 | |
| TEISGNSPVSPNTQD | 1281 | Q2LD37 | |
| PLSNSSETPVVATEE | 236 | Q06547 | |
| SLPTSPSDEVGRRQS | 2706 | Q15751 | |
| VETNQTRGSLSPEPT | 531 | Q8N187 | |
| VRTDTQSPTNTGSPS | 1091 | O15018 | |
| RSGSPSSQLPNVDEQ | 536 | Q9H5P4 | |
| SQPRSSLTAVTQPTE | 31 | Q9NTX9 | |
| TPVVESARPNSTSSR | 946 | Q8WXX7 | |
| RLIIESPSNTSSTEP | 561 | P38432 | |
| EIQPSRASPTSDIES | 641 | Q96JK2 | |
| SVVSRTDSPSPTVLN | 46 | Q8NC54 | |
| NEIRENSPAVSPTTN | 526 | Q9Y2L9 | |
| IPNRDSGIDSPSSSV | 71 | Q5JSP0 | |
| LPTDPRAQEDNSVTS | 281 | Q7Z5B4 | |
| EISRPQAPDQSDSSQ | 271 | O94927 | |
| GQISTARPVQDTDSP | 626 | Q9UN70 | |
| SRTGSVQTPPDLESS | 1161 | P28290 | |
| SEQEVPPGTTESVQS | 211 | P52756 | |
| VLSTDTQTSPEPGTR | 196 | P29375 | |
| PNSTERAVTISGTPD | 171 | P57721 | |
| NDNAPEITVSSITSP | 341 | Q9Y5F1 | |
| EITVSSITSPIPENT | 346 | Q9Y5F1 | |
| QASETSRPSSPEITI | 341 | Q96NX5 | |
| NDNAPEITVSSITSP | 341 | Q9Y5F2 | |
| EITVSSITSPIPENT | 346 | Q9Y5F2 | |
| DVATSPISPTENNTT | 216 | Q13153 | |
| ENNTTPPDALTRNTE | 226 | Q13153 | |
| DAASNSVTETPPITQ | 556 | Q96HA1 | |
| NITIQATTTGREPPD | 566 | P87889 | |
| NITIQATTTGREPPD | 566 | Q9YNA8 | |
| NITIQATTTGREPPD | 566 | P62683 | |
| NITIQATTTGREPPD | 566 | P63145 | |
| NITIQATTTGREPPD | 566 | Q7LDI9 | |
| NITIQATTTGREPPD | 566 | P63130 | |
| NITIQATTTGREPPD | 566 | P62685 | |
| NITIQATTTGREPPD | 566 | P63126 | |
| NITIQATTTGREPPD | 566 | P62684 | |
| RPTETNPVTSNSDEE | 666 | P46100 | |
| ERTNIQVTVTGPSSP | 1201 | Q6YHK3 | |
| TNRPINPSTGELSTS | 301 | P23508 | |
| QIPPEDTASTRSSFT | 271 | P40189 | |
| QADSARPEQSSQSPV | 166 | Q0VDD7 | |
| PETPNSTISREASTQ | 6 | Q9NQZ3 | |
| PETPNSTISREASTQ | 171 | Q9NQZ3 | |
| PETPNSTISREASTQ | 336 | Q9NQZ3 | |
| RENTEPSSTQFQVPS | 196 | Q4AC94 | |
| LTNPSLRSPEESTES | 216 | Q8TD26 | |
| PAQTEAAASTEPATR | 51 | Q8N8A6 | |
| SGSTESLNPRPQTTI | 531 | Q96JB2 | |
| SFRTASVSINQTEPP | 426 | P29317 | |
| LASSESETEQPTPRQ | 116 | Q9UMQ3 | |
| EPQEPNSATSTTIAV | 3711 | Q8N3K9 | |
| EPSQQPGSNETLRTT | 526 | Q8NCU4 | |
| EQQVTESPSLASVPT | 2476 | Q5VT06 | |
| ATPQPQSGDTTVETN | 3656 | Q12955 | |
| STAVSEQAPTEQSPT | 1256 | P08519 | |
| SPVSEERSVQQSHPT | 516 | Q9NS15 | |
| ERSVQQSHPTATTTP | 521 | Q9NS15 | |
| VPVNSDDSPQQTSRA | 251 | Q8IYD9 | |
| EATTESSISLQPLQP | 271 | Q8IYV9 | |
| PETPNSTISREASTQ | 6 | Q92904 | |
| PETPNSTISREASTQ | 6 | Q86SG3 | |
| PETPNSTISREASTQ | 171 | Q86SG3 | |
| SVSENEGISTIPSPV | 711 | Q8NEL9 | |
| TSVTVTLTDVNDNPP | 246 | Q9ULB5 | |
| SESTEQTPSRPSQLD | 1001 | Q9Y2H2 | |
| NSSLTGESEPQTRSP | 226 | P20648 | |
| EPTVAPSQVSANSLS | 801 | Q9P232 | |
| SPDSPRSIDSNSEIV | 1041 | P42702 | |
| DPPRLQGVTETTDTS | 581 | Q8WUT4 | |
| EPVLTQTSEQAPSSA | 406 | P23468 | |
| QTSEQAPSSAPRDVQ | 411 | P23468 | |
| PVSNTPVANSEASTL | 1461 | Q685J3 | |
| PVDSNSPVITSTEVS | 2126 | Q685J3 | |
| TTSSPGVIVPESSEN | 61 | O75496 | |
| PTPSQTRLATQLTEE | 51 | Q9Y3C5 | |
| LSQETEIPTPQASLS | 326 | Q9Y4G2 | |
| TTVATVLPSNATEPA | 16 | P21579 | |
| AQTTPLAATEAQTTP | 161 | Q14242 | |
| RTPPVTEGSLSDTDN | 181 | Q9BQF6 | |
| RPSVQIDSGSSVPSD | 221 | Q96M34 | |
| SVPSDQSPSVQIDSG | 231 | Q96M34 | |
| QIDSGSSVPSDQRPS | 241 | Q96M34 | |
| VVTAPPSSSQSAEVL | 66 | Q9BYH1 | |
| ETARQETAQISSNPP | 161 | O75674 | |
| VRPEDTPSDLSVSNS | 361 | Q8TF05 | |
| SIGDSTPQQQSSPLR | 46 | O75159 | |
| QPESVDVITSQSDSP | 1316 | Q6T4R5 | |
| RTGPDQPLRQESSST | 116 | Q8TCY5 | |
| QEQPSIESTSPISRT | 1641 | Q5T5P2 | |
| PQSSPADSEQRVSET | 361 | Q2M3G4 | |
| SNSANIVPETSPESV | 436 | Q9NP59 | |
| VQRESSPSLSSTPVV | 136 | Q8N6D2 | |
| QTTSVSPDPTRESVL | 396 | Q68BL8 | |
| TAEAPNTTAGQVPTT | 316 | P40967 | |
| VAVPSSRSNSATEQP | 326 | Q13546 | |
| RRPVSVSPSSSQEIS | 896 | Q5T5C0 | |
| LEPRTETDSVGTPQS | 266 | Q9H0H5 | |
| NITIQATTTGREPPD | 566 | P63128 | |
| VTVTSRASNSAVPPA | 591 | Q9UQC9 | |
| QPSPRTVVATATGAE | 61 | Q8NFD4 | |
| GPIITRSDETPTNNS | 341 | Q8TCW7 | |
| RSDETPTNNSQLGSP | 346 | Q8TCW7 | |
| TSSSTPRENASVPEL | 641 | Q2QGD7 | |
| HTPSSSQEREQTPSE | 231 | Q9BW04 | |
| VQSSPVERPSTSTAV | 1801 | P12270 | |
| SAATTPTVENEQPSL | 516 | Q9BQI5 | |
| SPSQIEVSALSSDPQ | 26 | Q6ZQN7 | |
| SERNSTEALTEVPPT | 191 | Q9NVW2 | |
| DTPRSVASPETQLGN | 21 | A6NJL1 | |
| SIPSQTLPSTTEQQG | 481 | Q9UHP3 | |
| TEGRVSPSPSQESLS | 556 | Q5JSH3 | |
| LPESSNDRPVTANTT | 191 | Q9HCK1 | |
| SESIPTPSNREETQQ | 81 | P01241 | |
| GQQSTATLTPSPREE | 1146 | Q9HCK4 | |
| VQPLERSQEGPSSTS | 1226 | Q2M1Z3 | |
| ARNDSPTQIPVSSDV | 671 | Q8TC07 | |
| QQTSSRPPASVGELS | 826 | Q9UPT8 | |
| PQTNQLETGASSPER | 421 | Q9HC78 | |
| QVPTNTETSEETRPS | 1176 | Q96JG9 | |
| VSLTTGQPVDQPTTE | 136 | Q9H582 | |
| QSQVEEDVSSPPQRS | 21 | Q92536 | |
| PRTEAPVSSVSNSLE | 56 | Q8WYQ9 | |
| AQRSPEASQTDSPVE | 316 | O95049 | |
| LQVTSPEENISTLSP | 991 | Q86YA3 | |
| SPQNSTDSVSDIVPD | 211 | Q14694 | |
| TAISPEPQTLASTEQ | 11 | Q8TF39 | |
| QTPRPGSAESALSVQ | 331 | Q9ULC8 | |
| PQTSRISQEQVPEAS | 161 | Q8N680 | |
| SPPNDISTSVIQSEV | 1361 | Q9H4A3 | |
| ENPSTREIATTDTPL | 1876 | Q5T5U3 | |
| DSSNAVGPPTTVRVT | 601 | Q8IWU6 | |
| NPGRNLTVETQTTSS | 31 | Q9HD43 | |
| STPERQSSPSGSEQL | 446 | O15231 | |
| FSRSESADQTVSPPT | 676 | P15822 | |
| TRQQFTVSSGESPPL | 1261 | Q562E7 | |
| TEENSESQSPQSRLP | 121 | Q6SJ96 | |
| SNLVTQEPSPEETST | 191 | Q99676 | |
| SQRNAETPAETPTTA | 196 | Q9NUA8 | |
| ASPGSRTSPQELSEE | 296 | Q96PU5 |